SCHEMBL24081981

SCHEMBL24081981

CCOC(=O)C(=O)C(CCC=O)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP2D6 P10635 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 3/20 0.37
NPSR1 Q6W5P4 1/20 0.34
GLO1 Q04760 1/20 0.34
FAAH O00519 2/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ZDHHC7 Q9NXF8 1/20 0.31
DHODH Q02127 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852844 0.88 CA1 (0.32) SMN1; SMN2CA1CA2ZDHHC7
SCHEMBL4302611 0.82 CA1 (0.36) ALDH1A1SMN1; SMN2MAPTCA1CA2
SCHEMBL25224860 0.81 TSHR (0.40) ALDH1A1SMN1; SMN2MAPTNPSR1CA1
SCHEMBL24082020 0.79 TSHR (0.44) ALDH1A1SMN1; SMN2MAPTCA1CA2
SCHEMBL7518295 0.78 GAA (0.39) ALDH1A1CYP2D6SMN1; SMN2MAPTNPSR1
SCHEMBL24082211 0.78 TSHR (0.42) ALDH1A1MGAMGAASIMGAM2
SCHEMBL22310267 0.77 MAPT (0.40) ALDH1A1CYP2D6SMN1; SMN2CYP2C19MAPT
SCHEMBL29954187 0.77 CA1 (0.33) SMN1; SMN2MAPTCA1CA2ZDHHC7
SCHEMBL7337554 0.76 MAPT (0.44) ALDH1A1CYP2D6CYP2C19MAPTMGAM
SCHEMBL4302618 0.73 MAPT (0.42) ALDH1A1CYP2D6SMN1; SMN2CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919484-A1 HEXONE GLUCOKINASE INHIBITOR AND USE THEREOF Shandong Xuanzhu Pharma Co., Ltd. (CN) 2021-12-08 EP disclosed